「for」の検索結果
127件：91～95件目を表示
-
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708_0.pdf -
General Announcement: July 8, 2024 Senju Pharmaceutical Co., Ltd. Notice of Orphan Drug Designation for SJP-0008 as a Treatment of Central Retinal Artery Occlusion Senju Pharmaceutical Co., Ltd. (Head...
https://www.senju.co.jp/sites/default/files/content_news/2024-07/ENG_20240708.pdf -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
sium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining the function and transparency of the cornea. pH, osmotic pressure ratio, and viscosi...
http://www.senju.co.jp/english/products/myteara.html -
NewMytear A | OTC Products, etc. | Products | SENJU Pharmaceutical
sium, and calcium was made closer to normal tears. This medicine contains calcium that is important for maintaining the function and transparency of the cornea. pH, osmotic pressure ratio, and viscosi...
https://www.senju.co.jp/english/products/myteara.html -
. The OptiLight M22 IPL Model is the newest IPL treatment device equipped with a system specialized for the ophthalmology field. This OptiLight M22 IPL Model is indicated for improvement of symptoms o...
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101_0.pdf